Cannabidiol (CBD), a compound found in Cannabis sativa, has emerged as a substance of interest in the medical community due to its potential therapeutic benefits for various neurological and mental disorders. This comprehensive review examines the current scientific understanding of CBD’s effects on brain function, its potential as a therapeutic agent, and the ethical and …
Morus alba, a member of the Moraceae family, is not only known for its role in sericulture but also for its therapeutic potential. The plant’s traditional uses are backed by scientific research, indicating its effectiveness in various medical conditions. Highlights: Morus alba is utilized in traditional medicine for its analgesic, antibacterial, antidiabetic, and anti-inflammatory properties. …
Caffeine, a natural stimulant found in various plants, is renowned for its pervasive presence in coffee, tea, and numerous other beverages. Its role in human health extends far beyond just keeping us awake. Extensive research has evaluated its multifarious impacts on diseases, athletic performance, and even its future in nanotechnology-based delivery systems. Highlights: Caffeine and …
Quercetin, a potent flavonoid found abundantly in nature, stands at the forefront of promising therapeutic agents due to its extensive range of biological activities. However, its clinical application is significantly hampered by poor bioavailability and low solubility. Key Facts: Quercetin is celebrated for its anti-cancer, anti-inflammatory, and antioxidant properties. It faces bioavailability challenges due to …
Pantoprazole and Omeprazole are medications classified as proton-pump inhibitors (PPIs) and are commonly prescribed for the management of medical conditions in which stomach acid reduction is of therapeutic benefit. Chemists at Byk Gulden, a subsidiary of Altana (a German chemical company), are credited with the synthesis of pantoprazole in 1985 – whereas Swedish chemists at …
Lexapro (escitalopram) and Prozac (fluoxetine) are two medications within the selective-serotonin reuptake inhibitors (SSRI) classification that are commonly administered for the treatment of neuropsychiatric disorders. The development of Lexapro (escitalopram) was initiated in 1997 by Lundbeck and Forest Laboratories – whereas the development of Prozac (fluoxetine) was initiated in the 1970s by chemists (Bryan Molloy …
Lyrica (pregabalin) and Neurontin (gabapentin) are both classified as “gabapentinoids” (i.e. α2δ ligands). As gabapentinoids, Lyrica (pregabalin) and Neurontin (gabapentin) are chemical analogues of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) that interact with α2δ subunit-containing voltage-dependent calcium channels. Development of gabapentin (Neurontin) was initiated in the 1970s by chemists at the pharmaceutical company Parke-Davis – …